Increased numbers of T regulatory (T reg ) cells are found in B-chronic lymphocytic leukemia, but the nature and function of these T regs remains unclear. Detailed characterization of the T regs in chronic lymphocytic leukemia has not been performed and the degree of heterogeneity of among these cells has not been studied to date. Using 15-color flow cytometry we show that T reg cells, defined using CD4, CD25, and forkhead box P3 (FOXP3), can be divided into multiple complex subsets based on markers used for naïve, memory, and effector delineation as well as markers of T reg activation. Furthermore FOXP3 þ cells can be identified among CD4 þ CD25 À as well as CD8 þ CD4 À populations in increased proportions in patients with chronic lymphocytic leukemia compared with healthy donors. Significantly different frequencies of naïve and effector T regs populations are found in healthy donor controls compared with donors with chronic lymphocytic leukemia. A population of CCR7 þ CD39 þ T regs was significantly associated with chronic lymphocytic leukemia. This population demonstrated slightly reduced suppressive activity compared with total T regs or T regs of healthy donors. These data suggest that FOXP3-expressing cells, particularly in patients with chronic lymphocytic leukemia are much more complex for T reg sub-populations and transitions than previously reported. These findings demonstrate the complexity of regulation of T-cell responses in chronic lymphocytic leukemia and illustrate the use of high-dimensional analysis of cellular phenotypes in facilitating understanding of the intricacies of cellular immune responses and their dysregulation in cancer.
Chronic lymphocytic leukemia is one of the most common leukemias in adults in the Western hemisphere and is characterized by a slow, progressive accumulation of monoclonal B lymphocytes. Among patients with chronic lymphocytic leukemia, the progress of disease and response to therapy varies greatly for largely unknown reasons. Although chronic lymphocytic leukemia is a disease of B lymphocytes, a number of abnormalities in the T-lymphocyte compartment of the immune system have previously been described in patients, suggesting that an altered immune response occurs in response to the leukemia, or is a causal factor in the escape of the leukemic cells from normal immune recognition (Table 1) . [1] [2] [3] [4] [5] [6] [7] [8] Among the observed T-cell alterations is the intriguing finding of elevated frequencies of T regulatory (T reg ) cells in the peripheral circulation of patients with chronic lymphocytic leukemia. 5, [7] [8] [9] [10] Natural T reg cells in humans are most often characterized as CD4 þ T cells with high expression of CD25 and the transcription factor forkhead box P3 (FOXP3), a master regulator of T regs . T regs are also generally agreed upon to demonstrate a phenotype of CTLA-4 þ , CD62L þ , CD127 low , and GITR þ . 11, 12 In the peripheral circulation of healthy adults and elderly individuals, the majority of T regs express CD45RO, and are termed as effector T regs , which might reflect differentiation of either natural T regs derived from the thymus or induced T regs derived from memory cells in the peripheral circulation. [13] [14] [15] [16] 
CD45RA
þ T regs predominate in cord blood, but persist into adulthood, where they represent a minority of T regs in the peripheral circulation. 17 The percentage of CD45RA expressing T regs decreases with increasing age in adults. 18 A number of other T reg subsets have been described by the expression of various markers. Some of these have been associated with increased T reg suppressive activity, including CD39, HLA-DR, and CD103.
Using CD4 þ CD25 high expression to identify T regs , Beyer et al 5 found increased percentages of T reg in chronic lymphocytic leukemia compared with agemismatched healthy donors, and noted a correlation between the frequency of T regs and stage of disease using the Binet staging classification. Giannopoulos et al 6, 10 similarly noted an increase in the percentage of T regs in chronic lymphocytic leukemia using CD4 þ CD25 high FOXP3 to identify T regs . Although they also found a correlation between the frequency of T regs and Binet stage, they found no significant correlation with ZAP-70 or CD38. Using CD4 þ
CD25
bright CD127 low to identify T regs , Jak et al 7 found an increase in the absolute number of T regs in chronic lymphocytic leukemia and reported that the percentage of T regs increase with increasing stage of disease using the Rai classification. This group also reported a predominance of CD45RO þ T regs in these patients, suggesting that these cells arise from the memory T-cell pool in a CD70-dependent manner and accumulate due to reduced apoptosis. 7 Recently, Weiss et al, 19 using CD3 þ CD4 þ CD25 þ CD127 À to identify T regs , found a significant elevation of percentage of T regs in chronic lymphocytic leukemia compared with age-mismatched healthy control donors. This group further determined that T regs are an independent predictor of time to initial treatments in these patients. In the study by Weiss et al, 19 the percentage of T regs correlated with unmutated IgVH, high CD38 expression, as well as specific cytogenetic findings.
It is thought that T regs facilitate progression of disease in chronic lymphocytic leukemia, as well as in solid tumors, by suppressing T-cell anti-tumor responses. 20 In chronic lymphocytic leukemia, therapy with fludarabine, thalidomide, or lenalidomide has been reported to reduce the frequency, and limit the function, of T regs in these patients, 5, 6 suggesting the efficacy of these therapies might be due at least in part to effects on T regs . Chronic lymphocytic leukemia is also strongly associated with a progressive immunodeficiency in these patients and it has also been speculated that T regs arising in this disease might be a cause of the autoimmune complications. 21 T regs found in chronic lymphocytic leukemia patients neither have been characterized in any great detail nor have definitive reasons for their increased frequency in chronic lymphocytic leukemia been delineated.
In the current study, high-resolution phenotyping of T-cell subsets and characterization of T reg subpopulations in the circulation of chronic lymphocytic leukemia was accomplished using the 15-color immunophenotyping that included markers to identify T regs as well as those reported to be associated with naïve, memory, and suppressive activity in T cells. This permits more rigorous examination of T regs to discern complex phenotypes that may differ from those of healthy donors or that may correlate with progressive disease or the mutational status of the malignant population in chronic lymphocytic leukemia. Using probability state modeling (PSM) [22] [23] [24] these complex T reg phenotypes were then analyzed to better understand marker correlations defined by the high-dimensional data. A selected T reg subset identified in this manner was sorted and assayed for suppression of autologous T-cell responses.
Materials and methods

Patient Samples
Peripheral blood specimens from 21 patients with B-chronic lymphoid leukemia and 16 age-matched healthy donors were studied. Peripheral blood from healthy donors enrolled in the NHLBI study 09-H-0201 and 09-H-0229 was collected into vacutainer tubes containing sodium heparin. Written informed consent for all procedures and research collections was obtained. Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation over Lymphocyte Separation Medium (LSM, ICN Biomedicals, Aurora, OH). Cells were viably frozen and kept in fetal calf serum containing 10% dimethyl sulfoxide and stored in liquid nitrogen. Peripheral blood was collected from treatment naïve chronic lymphocytic leukemia patients with RAI scores of 2 or less enrolled in the NCI study 97-C-0178 (ClinicalTrials.gov Identifier: NCT00019370) ( Table 2 ). Mononuclear cells were isolated and viably frozen in a similar manner to the healthy donor cells. For all chronic lymphocytic leukemia patients, data were collected on whether the tumor cells expressed a mutated (m-chronic lymphocytic (Figure 1a) . Among the T reg population, as previously performed for CD4 and CD8 cells, we identified naïve
Cell Sorting of T regs
PBMCs were isolated by density gradient centrifugation over LSM. Figure 1 Gating strategy to identify T regulatory (T regs ) population in chronic lymphocytic leukemia patients and CD4 and CD8 characterization. Single-cell suspensions from chronic lymphocytic leukemia were stained with a combination of 14 antibodies and a viable dye as described in Materials and methods. (a) Lymphocytes were identified based on their forward-and side-scatter properties. Subsequently, dead cells were excluded through the use of a viability dye. CD45 and CD3 were used to identify T cells (CD45 þ CD3 þ ) among the previously selected viable lymphocytes. CD4 T cells and CD8 T cells were identified as uniquely expressing CD4 or CD8 antigens. Conventional T regs were defined as CD4 T cells co-expressing CD25 and transcription factor forkhead box P3 (FOXP3). CD127 expression was measured in FOXP3-expressing cells. CD25
À T regs were defined as CD4
In addition to T regs memory and naïve compartment of CD4 and CD8 was described. The graphs display the percentages (the mean percentage values ±s.e.m. are indicated by the bars) of naïve vs memory sub-population CD4 T cells (b) and CD8 T cells (c) in healthy donors (black circle) and chronic lymphocytic leukemia (gray square). (d) A probability state model constructed with GemStone (Verity Software House) was applied to CD4 T cells and CD8 T cells from healthy donors and from chronic lymphocytic leukemia. For these displays, the data were gated on light scatter, viability, and expression of CD45, CD3, and either CD4 or CD8 as described earlier. The y-axis is relative fluorescence intensity, whereas the x-axis displays staged progression from naïve to memory (CM, EM) and effector (EC) compartments. The width of each stage (naïve, EM, CM, EC) indicates the percentage of cells falling into these categories. The width of the bands corresponds to the variability of the data as the cells progress. These graphs reveal the same proportions of memory and naïve subsets as in the previous figures, although here it is possible to visualize relative intensity of marker expression along with putative transitions among these populations. 
Statistical Analysis
Data obtained with cells from one donor were considered as one experiment (n). Statistical analysis performed on the results included the calculation of mean, s.e., and P-values by use of a multiple comparison test (two-way ANOVA test) or MannWhitney test (non-parametric t-test). Correlations between parameters were calculated using the Spearman's correlation, and Spearman's r factor was reported. The significance level was set at P ¼ 0.05, and the P-values were given for each series of experiments.
Results
Assessment of CD4 þ and CD8 þ T-Cell Subsets
The initial analysis of these data was carried out to determine whether there were differences in the frequencies of CD8 þ and CD4 (Figures 1b-d) . The frequency of naïve CD4 þ population was increased in chronic lymphocytic leukemia, representing 34.4 ± 4.1% vs 24.4 ± 3.6% in healthy donors (P ¼ 0.06; Figure 1b) , whereas the proportion of naïve CD8 þ was unchanged: 45.4±4% in chronic lymphocytic leukemia vs 38.2 ± 3.5% in healthy donors (P ¼ 0.27; Figure 1c) . A lower frequency of CD4 þ ECs was observed in blood from chronic lymphocytic leukemia patients compared with healthy donors (8.8 ± 2.1% vs 16.8 ± 3.6%, P ¼ 0.03), but the proportion of CD8
þ ECs was unchanged. By contrast, the frequency of CM CD4 þ T cells was higher in chronic lymphocytic leukemia compared with healthy donors (11.8±2.4% vs 5.9±1.1%, P ¼ 0.05) and the frequency of CM CD8
þ T cells was lower in chronic lymphocytic leukemia compared with healthy donors (0.3±0.09% vs 2.2±0.5%, P ¼ 0.0001; Figure  1c ). Among both CD8
þ T cells and CD4 þ T cells, the proportion of EM cells was unchanged.
T regs and T reg Memory and Naïve Sub-populations
T reg cells was significantly higher in chronic lymphocytic leukemia patients compared with healthy donors (12.8 ± 1.3% vs 5.4 ± 0.4%, Po0.0001; Figure 2a ). Flow cytometric analysis confirmed that the majority of T regs in healthy donors was CD45RA À (90.6 ± 1.7%), whereas in chronic lymphocytic leukemia patients, T reg cells were found in both CD45RA À and CD45RA þ populations. In chronic lymphocytic leukemia, naïve T reg cells were significantly expanded compared with healthy donors (43.5±4.7% vs 11.9±1.4%, Po0.0001; Figure 2b ). Among the CD45RA À populations, T reg cells identified as EM (CD45RA À CCR7 À CD27 þ ) were decreased in chronic lymphocytic leukemia compared with healthy donors (37.4 ± 4.4% vs 77.7 ± 1.2%, Po0.0001; Figure 2c ). The frequency of CM (CD45RA
T reg was unchanged (8.6 ± 1.3% in chronic lymphocytic leukemia vs 5 ± 0.7% in healthy donors, P ¼ 0.62; Figure 2d ). The proportion of effector T reg cells was reduced in chronic lymphocytic leukemia compared with healthy donors (1.7 ± 0.4% vs 7.6 ± 1.1%, Po0.0001; Figure 2e ).
High-Resolution Immunophenotyping of T reg Cells
To further characterize the phenotype of natural and healthy donors, the cell surface expressions of HLA-DR, CD38, CD103, and CD39 were measured (Figure 2f ). The frequencies of T regs expressing CD38, HLA-DR, or CD103 were not significantly different between healthy donors and chronic lymphocytic leukemia. Nevertheless, another activation marker, CD39, was increased in T regs from chronic lymphocytic leukemia patients compared with healthy donors (66.5 ± 5% and 49.1 ± 5.9%, respectively, P ¼ 0.01). In healthy donors, natural T regs are CD127 low (Figure 1b) , 11 but CD127 expression in chronic lymphocytic leukemia T regs was increased (27.8±3.1% in chronic lymphocytic leukemia vs 8.2±1.1% in healthy donors, Po0.0001).
In addition to examining expression of activation markers in the overall T reg population, a combination of these activation markers was examined. In chronic lymphocytic leukemia, a significant increase of the double-positive CD39 þ CCR7 þ T reg population was observed compared with healthy donors (37.8 ± 5% and 4.1 ± 0.7%, respectively, Po0.001). Consequently, the double-negative T reg population was lower in chronic lymphocytic leukemia than in healthy donors (32.9±4.3% and 48.8 ± 5.6%, respectively, Po0.001). Figure 3 shows representative dot plots of the expression of CD39 vs CCR7 in a healthy donor (Figure 3a) and in a chronic lymphocytic leukemia (Figure 3b) . In chronic lymphocytic leukemia, the dual-positive CD39 þ CCR7 þ T regs were primarily CD45RA þ : 86.5±3.5% compared with 5.9 ± 2% in healthy donors (Po0.001).
The same activation markers were studied among the memory/naïve T reg sub-populations (Table 3) . A different pattern of activation was observed among the T reg in chronic lymphocytic leukemia patients: naïve T reg expressed more CD38, CD39, CD127, and HLA-DR compared with healthy donors (two-to threefold increase, Po0.0001). In the CM T reg subpopulation, HLA-DR expression was significantly decreased in chronic lymphocytic leukemia patients (Po0.0001). In the EM T reg sub-population, CD127 and HLA-DR expression was lower in chronic lymphocytic leukemia patients compared with healthy donors; conversely, CD38 expression was higher in chronic lymphocytic leukemia compared with healthy donors. Finally, in the effector T reg subpopulation, HLA-DR expression was significantly decreased in chronic lymphocytic leukemia patients (P ¼ 0.006), and CD38 was also decreased (P ¼ 0.003).
Analysis of T reg -Mediated Suppression of Polyclonal T-Cell Responses
To evaluate the in vitro suppressive capacity of T regs toward responder T effec cells, CD4 þ CD25 high T cells (T reg ) and CD4 þ CD25 À T cells (T effec ) were sorted from seven healthy donors and five chronic lymphocytic leukemia patients (Figure 3c ). Subsequently, the sorted cells were used to setup an autologous coculture assay as described in Venken et al. 32 Fifty thousand CFSE-labeled CD4 
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suppressed the proliferation of autologous responder cells in coculture in a dose-dependent manner, the mean relative inhibition for T effec /T reg ratio 1:1 was 22 ± 7.1% for healthy donors. Among the chronic lymphocytic leukemia patients the mean suppression at a 1:1 T resp /T reg ratio was 16.4 ± 2%. The difference between the mean suppression in healthy donors and in chronic lymphocytic leukemia for T effec /T reg ratio 1:1 was not significant (P ¼ 0.43). In healthy donors, there are virtually no CD39 þ CCR7 þ T regs , thus, we were not able to sort this specific population for the proliferation assay experiment, and it was impossible to perform this control. In chronic lymphocytic leukemia, the relative inhibition of CD39 þ CCR7 þ T reg was measured as performed for total T reg , and was compared with the suppression obtained by the total T reg population in chronic lymphocytic leukemia. A trend to slightly less suppression was observed in this T reg sub-population compared with the total T reg population in chronic lymphocytic leukemia (1:1 mean suppression ¼ 12.5 ± 1.2%, (P ¼ 0.59)). Comparing the mean suppression of CD39 þ CCR7 þ T reg with total T reg in healthy donors, showed a trend to a lower suppressive capacity, 12.5±1.2%, vs 22±7.1%, but did not reach significance (P ¼ 0.24).
PSM of CD4 þ and CD8 þ T-Cell Subsets in Healthy Donors and Chronic Lymphocytic Leukemia
Understanding the relationship of multiple markers to each other using bivariate plots and Boolean gating is difficult, particularly when attempting to evaluate 15-color immunophenotyping. To better understand these data, probability state models were constructed for CD4 þ and CD8 þ T cells in healthy donors and in chronic lymphocytic leukemia (Figure 1d ). The use of these models emphasized the difference in the relative intensity of each marker in all populations from healthy donors and chronic lymphocytic leukemia, allowing an understanding of the behavior of each marker at through the progression to maturation. These models display intensity and frequency as a continuum for each marker studied to show the progression of CD4 þ or CD8 þ T cells from naïve to memory and ECs. The discrimination between memory and naïve population was performed according to the gating Figure 1d shows a comparison of the Ag-dependent partitioning of events as determined by CD45RA, CD197, and CD27 marker downregulations in both CD4 þ T cells (left panels and CD8 þ T cells right panels) using data from a single donor. For CD4 þ T cells, the healthy donor's naïve, CM, EM, and EC fractions were 24.9%, 5.6%, 61%, and 8.8%, respectively. The chronic lymphocytic leukemia fractions were 13%, 10%, 67.3%, and 9.7%, respectively. For CD8 þ T cells, the healthy donor's naïve, CM, EM, and EC fractions were 37.6%, 3.7%, 53.6%, and 5.1%, respectively. The chronic lymphocytic leukemia fractions were 36.2%, 1.9%, 52.4%, and 10.6%, respectively. The chronic lymphocytic leukemia patient had decreased naïve and CM phases as well as increased EM and EC phases compared with the healthy donor patient.
PSM of T regs Cells in Healthy Donors and Chronic Lymphocytic Leukemia
To simplify and better understand the complex relationship of marker expressions among T reg populations, PSMs were designed for T reg cells as described in a previous section (Figure 4a ). An increase in the proportion of naïve T reg cells was observed in chronic lymphocytic leukemia patients compared with healthy donors. Activation markers such as CD39, CD38, and HLA-DR presented a higher relative intensity in chronic lymphocytic leukemia patients compared with healthy donors (Figures 4b-d) . CD25 and CD127 presented a different pattern of expression in the EM T reg compartment (Figure 4e ).
FOXP3 Expression in CD4
þ CD25 À T Cells in Chronic Lymphocytic Leukemia Patients During the evaluation of the numbers of T reg cells in healthy donors and in chronic lymphocytic leukemia patients, it was noted that among the CD4 þ Tcell population (Figure 1a) there was a cell population expressing FOXP3 but not CD25 (
þ was significantly increased in chronic lymphocytic leukemia patients compared with healthy donors (4±1% vs 1.45±0.1%, P ¼ 0.0015; Figure 5a ). As for natural T regs , the proportion of naïve, EC, CM and EM cells was determined for the CD4
À cells in chronic lymphocytic leukemia (Figure 5b ). In chronic lymphocytic leukemia patients, 29.9 ± 4.5% of CD4 þ FOXP3 þ CD25 À cells were naïve, but the majority of these CD4
À cells, EM cells were predominant (57.8±5.4%), followed by CM (9.3±1.4%), and ECs (2.9±0.6%).
A trend toward a higher expression of CD127 among the CD4 þ FOXP3 þ CD25 À cells was observed in chronic lymphocytic leukemia patients compared with healthy donors (24.2 ± 3.4% in chronic lymphocytic leukemia vs 3 ± 0.4% in healthy donors (Po0.001)) and lower expressions of the activation marker HLA-DR was observed compared with healthy donors (52 ± 3.4% in healthy donors vs 32.6±4.8% in chronic lymphocytic leukemia, Po0.001; Figure 5c ). No significant differences were observed between healthy donors and chronic lymphocytic leukemia for the expression of CD103, CD39, and
Cells in Chronic Lymphocytic Leukemia Patients
Within the CD8 þ T-cell population, a cell population expressing FOXP3 and CD25 (FOXP3 þ CD25 þ ) was identified. The percentage of these CD8 þ
FOXP3
þ CD25 þ cells was significantly increased in chronic lymphocytic leukemia patients compared with healthy donors (11.2 ± 2.1% vs 0.4 ± 0.08%, respectively, Po0.0001; Figure 5d ). The proportion of CD8 þ FOXP3 þ CD25 þ cells defined as naïve, EC, CM, and EM cells was determined for chronic lymphocytic leukemia, but not for healthy donors, as there were not sufficient numbers of cell with this phenotype in the latter for this task (Figure 5e ). The . For these models, the data were gated on light scatter, viability, and expression of CD45, CD3, CD4, CD25
high , and FOXP3 as described earlier. The y-axis is relative fluorescence intensity, whereas the x-axis displays staged progression from naïve to memory and effector populations. The width of each stage (naïve, CM, EM, EC) indicates the percentage of cells falling into these categories. The width of the bands corresponds to the variability of the data as the cells progress. These graphs reveal the coordinate expression patterns of memory and naïve markers (a) as well as activation markers through the transitions (b, c and d). Panel e reveals the expression of all markers among the conventional T reg cells in a coordinated manner, with intensities of all markers revealed through the transitional steps.
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Correlation of Immunophenotypes with Prognostic Markers
The frequencies of T regs and of the various T reg subsets were analyzed for their correlation with known prognostic markers. Previous studies have reported that a combination of CD38 and ZAP-70 is the best predictor of disease progression. [33] [34] [35] Using the Spearman's correlation, we found that both CD45RA þ T reg and CD8 T reg were significantly inversely correlated with combined CD38 and ZAP-70 expression (Spearman's r ¼ À0.55 (P ¼ 0.02) and Spearman's r ¼ À0.58 (P ¼ 0.01), respectively In concordance with these studies we found an increase in the frequency of T regs in the peripheral circulation compared with age-matched healthy donors. The literature is divided on whether the frequency of T regs in chronic lymphocytic leukemia correlates with prognostic markers such as CD38, ZAP-70, or IgVH mutational status, and it remains unclear why these discrepancies occur. Several studies did find a correlation between the frequency of T regs and clinical stage, 6 ,10 but we found that the frequency of total CD4 þ T regs did not significantly correlate with prognostic markers. We found instead that specific sub-populations of T regs , CD4 þ CD45RA þ T regs , and CD8 þ T regs did show a correlation. These findings strongly suggest that elucidating the complex immunophenotypes of T regs found in chronic lymphocytic leukemia is necessary to understand their role in this disease progression.
We observed a significant increase of CD4 À CD8 À T cells in patients with chronic lymphocytic leukemia, these cells could be immature T cells, and could reflect the change on T-cell function induced by the presence of chronic lymphocytic leukemia cells. In addition to immature T cells, these doublenegative T cells could be iNKT cells, or gd T cells. þ CD25 þ T reg cells have been described using limited markers as belonging to the memory T-cell compartment. [13] [14] [15] [16] Valmori et al 40 identified a T reg -cell population with naïve phenotype (CCR7 þ CD45RA þ ), which they termed natural naïve T reg cells. Several observations have been made by other groups examining the naïve (CD45RA þ ) vs memory (CD45RO þ ) phenotype of T regs population. Among these observations are the findings of: (1) an increase of memory T regs in older HIV-infected patients, 41 (2) an increase of naïve T regs in younger healthy donors, 41 and (3) that the frequency, phenotypic characteristic, and antiproliferative function were comparable in the young (ageo40 years) and the elderly (age465 years). 42, 43 The current data demonstrate that T regs can readily be classified as naïve, EC, CM, and EM subsets using CD27, CCR7, and CD45RA. The NnT reg population, identified in the current study as viable
þ , is increased in the chronic lymphocytic leukemia patients compared with controls. Statistically significant differences between chronic lymphocytic leukemia patients and healthy donors were observed in EM T regs as well as in effector T regs using these classifications. The data suggest that simple identification of T regs as naïve or adaptive may be too superficial to draw meaningful conclusions regarding their function, as these cells lend themselves to further phenotypic compartmentalization as performed for CD4 þ T cells as a whole. By using these complex classifications, significant differences are observed in the T reg populations between chronic lymphocytic leukemia patients and healthy donors. The current data show in chronic lymphocytic leukemia patients averaging over 65 years of age, naïve T regs remain a predominant population, whereas in healthy donors, we showed a paucity of naïve T regs , consistent with previous reports. Booth et al 44 have demonstrated that human T regs expressing either CD45RA or CD45RO have identical suppressive capacity in healthy individuals, although the former are less proliferative. Interestingly, their data also show that CD45RA T regs express CXCR4 and preferentially accumulate in the bone marrow.
Within the T reg population, the chronic lymphocytic leukemia patients had patterns of marker expression, other than CD45RA, differing significantly from those in healthy donors, such as increased co-expression of CD39 and CCR7. CD39 has been closely associated with the suppressive activity of T regs . 45 Thus, dual-positive CCR7 þ CD39 þ T regs were speculated to be a highly suppressive phenotype. In five cases of chronic lymphocytic leukemia, the suppressive capability of the sorted T regs CD39 þ CCR7 þ was less than the total T regs from the same donor but this did not reach statistical significance. It was not possible to sort sufficient CD39 þ CCR7 þ T regs from healthy donors, as virtually none existed. However, compared with total T regs from healthy individuals, the CD39 þ CCR7 þ T regs unexpectedly showed a slightly reduced suppressive capability. These CD39 þ T regs might be highly activated but not necessarily highly suppressive. Another observation was an increased expression of CD127 in the T regs from chronic lymphocytic leukemia. Studies have shown that CD127 has an important role in the proliferation and differentiation of mature T cells, and in vitro experiments show that the expression of CD127 is downregulated following T-cell activation. 46, 47 Earlier studies showed that CD127 expression inversely correlates with the suppressive function of T regs . 48 The increase of CD127 could be linked to the naïve phenotype of our chronic lymphocytic leukemia T regs , as low expression of CD127 is a marker for natural T regs that have a memory phenotype, 7 and the chronic lymphocytic leukemia T regs have a naïve phenotype. This finding would suggest that care should be taken when using low CD127 expression to define T regs in these patients, and possibly in patients with other forms of cancer. Taken as a whole, our data indicate that it is possible to delineate many putative subtypes of T regs cells using widely studied markers. 49 In the context of chronic lymphocytic leukemia, as well as other neoplastic diseases, ascribing the regulation of immune responses by T regs might be a far more complex process than simply measuring CD4 þ CD25 þ FOXP3 þ cells. Much work remains to validate such speculation by sorting the populations of T regs identified by the 15-color immunophenotyping and elucidating the function of each. It is hoped FOXP3 and Treg subsets in Chronic Lymphocytic Leukemia that the high-dimensional immunophenotyping of T regs demonstrating numerous distinct sub-populations presented here will serve as an impetus for such studies.
